Dartmouth researchers have launched a clinical trial for Therabot, an AI-powered therapy app aimed at improving mental health care access and personalization.
Main Points:
- Therabot’s AI Technology: Utilizing generative AI, similar to OpenAI’s ChatGPT, Therabot provides personalized mental health support, learning from interactions to better serve individual user needs.
- Development and Training: The development team at Dartmouth has trained Therabot using a combination of peer support forum data, psychotherapist training materials, and newly created therapy transcripts to ensure high-quality, appropriate responses.
- Safety and Regulation Concerns: Despite the innovative approach, there are concerns about the safety and effectiveness of AI in therapy, highlighted by instances where AI apps like Tessa were criticized for potentially harmful advice.
Summary:
Dartmouth College’s latest venture into the intersection of technology and mental health introduces Therabot, an artificial intelligence-powered therapeutic app currently undergoing its first clinical trial. This app represents a significant step forward in mental health treatment, leveraging generative AI to simulate therapeutic conversations and provide personalized advice. Unlike existing AI therapy tools which often rely on predefined scripts, Therabot aims to deliver more nuanced and adaptive interactions, drawing from a broad range of therapeutic techniques and responses.
The project, led by Nicholas Jacobson, a clinically trained psychologist and assistant professor, has evolved over five years to ensure the AI’s responses are safe and effective. Initially, the AI was trained on existing online materials, but the team quickly realized the need for more tailored content, leading to the creation of bespoke therapy transcripts. This rigorous development process aims to ensure that Therabot can handle a variety of mental health issues effectively, without resorting to generic responses.
However, the deployment of such technologies is not without challenges. Previous instances, like the withdrawal of the Tessa app by the National Eating Disorders Association due to unsafe dietary advice, underscore the potential risks associated with AI in mental health settings. These challenges highlight the need for careful oversight and continuous refinement of AI tools to prevent harmful outcomes. As Therabot progresses through its trial phase, its developers remain vigilant, monitoring the AI’s interactions to mitigate any issues that arise, aiming for a tool that complements traditional therapy rather than replacing it.
Source: Dartmouth researchers look to meld therapy apps with modern AI
Keep up to date on the latest AI news and tools by subscribing to our weekly newsletter, or following up on Twitter and Facebook.
